Immuno-Positron Emission Tomography, Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06305728

Title field or adapter rule

{'original_value': 'Immuno-Positron Emission Tomography, Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:27.012205+00:00

Published At

2026-08-25T00:00:00+00:00

Record Updated At

2026-08-25

Source Retrieved At

2026-10-31T22:17:58.991924+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Cyst"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-08-25", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06305728"

protocolSection.identificationModule.officialTitle

"Immuno-Positron Emission Tomography, Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Cyst (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['High Risk Pancreatic Cystic Neoplasm'], 'description': 'Participants who choose to will undergo immunoPET before surgery.', 'name': '89Zr-DFO-HuMab-5B1 immunoPET', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['High Risk Pancreatic Cystic Neoplasm'], 'description': 'Participants who choose to will undergo HP MRI before surgery.', 'name': 'HP MRI', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['High Risk Pancreatic Cystic Neoplasm'], 'description': 'Will be drawn within 6 weeks of surgery and annually as post operative care', 'name': 'Blood assay', 'type': 'COMBINATION_PRODUCT'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.